4-[[4-[[4-(4-hydroxy-4-methylcyclohexyl)oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-ium-1-yl]methyl]oxan-4-ol
C26H39N2O6+ — CID 163694327
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[4-[[4-(4-hydroxy-4-methylcyclohexyl)oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-ium-1-yl]methyl]oxan-4-ol
4-[[4-[[4-(4-hydroxy-4-methylcyclohexyl)oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-ium-1-yl]methyl]oxan-4-ol (PubChem CID 163694327) has the molecular formula C26H39N2O6+ and a molecular weight of 475.61 g/mol. Its IUPAC name is 4-[[4-[[4-(4-hydroxy-4-methylcyclohexyl)oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-ium-1-yl]methyl]oxan-4-ol.
Molecular Properties
| Compound Name | 4-[[4-[[4-(4-hydroxy-4-methylcyclohexyl)oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-ium-1-yl]methyl]oxan-4-ol |
|---|---|
| PubChem CID | 163694327 |
| Molecular Formula | C26H39N2O6+ |
| Molecular Weight | 475.61 g/mol |
| Exact Mass | 475.28 |
| IUPAC Name | 4-[[4-[[4-(4-hydroxy-4-methylcyclohexyl)oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-ium-1-yl]methyl]oxan-4-ol |
| SMILES | CC1(O)CCC(Oc2cccc3onc(OCC4CC[NH+](CC5(O)CCOCC5)CC4)c23)CC1 |
| InChI | InChI=1S/C26H38N2O6/c1-25(29)9-5-20(6-10-25)33-21-3-2-4-22-23(21)24(27-34-22)32-17-19-7-13-28(14-8-19)18-26(30)11-15-31-16-12-26/h2-4,19-20,29-30H,5-18H2,1H3/p+1 |
| InChIKey | JVPXTARHLIQYRF-UHFFFAOYSA-O |
| XLogP | 2.12 |
| TPSA | 98.62 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 475.61 |
| LogP ≤ 5 | 2.12 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163694327 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.